CME Group Statistics

Total Valuation

CME Group has a market cap or net worth of EUR 100.24 billion. The enterprise value is 99.57 billion.

Market Cap	100.24B
Enterprise Value	99.57B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Dec 11, 2025

Share Statistics

Current Share Class	358.62M
Shares Outstanding	n/a
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	91.92%
Float	357.06M

Valuation Ratios

The trailing PE ratio is 29.27 and the forward PE ratio is 27.45.

PE Ratio	29.27
Forward PE	27.45
PS Ratio	18.09
PB Ratio	4.10
P/TBV Ratio	n/a
P/FCF Ratio	28.07
P/OCF Ratio	27.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.32, with an EV/FCF ratio of 27.88.

EV / Earnings	29.07
EV / Sales	17.87
EV / EBITDA	23.32
EV / EBIT	25.11
EV / FCF	27.88

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.13.

Current Ratio	1.03
Quick Ratio	0.03
Debt / Equity	0.13
Debt / EBITDA	0.81
Debt / FCF	0.90
Interest Coverage	24.56

Financial Efficiency

Return on equity (ROE) is 14.75% and return on invested capital (ROIC) is 11.34%.

Return on Equity (ROE)	14.75%
Return on Assets (ROA)	1.59%
Return on Invested Capital (ROIC)	11.34%
Return on Capital Employed (ROCE)	11.17%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.47M
Profits Per Employee	910,821
Employee Count	3,760
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, CME Group has paid 1.07 billion in taxes.

Income Tax	1.07B
Effective Tax Rate	23.61%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	242.83
200-Day Moving Average	236.84
Relative Strength Index (RSI)	57.82
Average Volume (20 Days)	27

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.56

Income Statement

In the last 12 months, CME Group had revenue of EUR 5.54 billion and earned 3.42 billion in profits. Earnings per share was 9.50.

Revenue	5.54B
Gross Profit	5.54B
Operating Income	3.63B
Pretax Income	4.54B
Net Income	3.42B
EBITDA	3.91B
EBIT	3.63B
Earnings Per Share (EPS)	9.50

Full Income Statement

Balance Sheet

The company has 3.87 billion in cash and 3.20 billion in debt, giving a net cash position of 668.33 million.

Cash & Cash Equivalents	3.87B
Total Debt	3.20B
Net Cash	668.33M
Net Cash Per Share	n/a
Equity (Book Value)	24.47B
Book Value Per Share	68.16
Working Capital	4.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.64 billion and capital expenditures -71.12 million, giving a free cash flow of 3.57 billion.

Operating Cash Flow	3.64B
Capital Expenditures	-71.12M
Free Cash Flow	3.57B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 65.46% and 62.58%.

Gross Margin	100.00%
Operating Margin	65.46%
Pretax Margin	81.92%
Profit Margin	62.58%
EBITDA Margin	70.54%
EBIT Margin	65.46%
FCF Margin	64.45%

Dividends & Yields

This stock pays an annual dividend of 3.33, which amounts to a dividend yield of 1.27%.

Dividend Per Share	3.33
Dividend Yield	1.27%
Dividend Growth (YoY)	-50.05%
Years of Dividend Growth	n/a
Payout Ratio	96.58%
Buyback Yield	-0.10%
Shareholder Yield	1.17%
Earnings Yield	3.42%
FCF Yield	3.56%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CME Group has an Altman Z-Score of 0.52 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.52
Piotroski F-Score	5